[Source: Joe Caspermyer, Biodesign Institute] – In an effort to advance knowledge of human cell biology to improve human health, Arizona State University’s Biodesign Institute will acquire the first commercially available Cell-CT™ imaging platform from VisionGate, Inc., a Seattle-based private company.
The acquisition places the Biodesign Institute at the forefront of a new generation of medical imaging technologies. The Cell-CTTM is a sophisticated optical instrument that employs patented computed tomographic (CT) scanning methods to generate high-resolution three-dimensional images of individual cells, allowing precise measurement of cellular anatomy and molecular markers important for understanding and identifying the earliest stages of disease.
For more information click here.